- Global Infectious Disease Epidemic Information Daily, May 15
- Global Infectious Diseases Information Daily, April 26
- Global Infectious Disease Epidemic Information Daily, 12 April
- Rapid Report on Global Infectious Disease Epidemic Information on January 26, 2019
- National Influenza Surveillance Information (Week 4, 2019)
- Global Infectious Disease Epidemic Information Daily, January 24
- Global Infectious Disease Epidemic Information Daily Jan. 11
- Survey of the epidemic situation of notifiable infectious diseases in China in December 2018
- Disclosure of Potential Conflicts of Interest(2019)
- Introduction letter template
- Self-check Report
- Disclosure of Potential Conflicts of Interest
- Information for Author
- Copyright Agreement
- Download of PDF reader
- Speech at the Opening Ceremony of the 30th National University Safety Science and Engineering Academic Conference
- Introduction to the first release of network version of "Disease Surveillance"
- Evaluation of academic papers with academic influence
- ANTIMICROBIAL RESISTANCE AND ONE HEALTH VIA WHOLE CHAIN
Display Method:
$v.abstractInfoEn
$v.abstractInfoEn
In May 2022, a total of 66 infectious diseases were reported globally, affecting 233 countries and regions. Except for influenza, the top five infectious diseases affecting greatest number of countries and regions were COVID-19 (233), monkeypox (36), dengue fever (31), measles (24) and cholera (11). The top five infectious diseases with highest case fatality rates were Ebola virus disease (100.0%), Middle East Respiratory Syndrome (34.4%), Crimean-Congo hemorrhagic fever (22.2%), Lassa fever (19.8%) and monkeypox (4.0%). The top five infectious diseases with greatest number of deaths were COVID-19, malaria, cholera, dengue fever and measles. The prevalent infectious diseases in Asia were COVID-19, dengue fever and cholera, the prevalent infectious diseases in Africa were COVID-19, Ebola virus disease, cholera, yellow fever, Lassa fever, malaria and monkeypox, the prevalent infectious diseases in America were COVID-19, dengue fever, chikungunya fever and Zika virus disease, the prevalent infectious disease in Europe were COVID-19, monkeypox and acute hepatitis of unknown aetiology.
$v.abstractInfoEn
$v.abstractInfoEn
$v.abstractInfoEn
$v.abstractInfoEn
The pandemic of COVID-19 continues to spread worldwide, suggesting that the epidemic would continue in natural state. Although some progress has been achieved in the treatment of COVID-19, it is far from containing the spread of the epidemic. Therefore, human beings have pinned their hopes of controlling the COVID-19 epidemic on the development of vaccines. Currently, several COVID-19 vaccine products have been applied to immunize the population after completion of phase Ⅲ clinical trials. The safety, immunogenicity, efficacy, immunization procedures and response to virus mutations of different COVID-19 vaccines are the great concern of the public. The public and experts in the field are confused about the efficacy of vaccines due to the different evaluation indicators used by research and development institutions in publishing vaccine development and application information and the interpretation by media from different perspectives and calibers. This paper summarizes the published research data and discusses the hot issues in development and post-marketing application of COVID-19 vaccine.
$v.abstractInfoEn
In May 2021, a total of 67 infectious diseases were reported globally, affecting 225 countries and regions. Except for influenza, the top five infectious diseases affecting greatest number of countries and regions were corona virus disease 2019(COVID-19, 225), dengue fever (30), measles (29), poliomyelitis (15) and malaria (9). The top five infectious diseases with highest case fatality rates were Ebola virus disease (52.2%), Middle East respiratory syndrome (34.4%), lassa fever (20.3%), plague (6.0%) and Crimean-Congo hemorrhagic fever (5.3%). The top five infectious diseases with greatest number of deaths were COVID-19, malaria, measles, dengue fever and cholera. The prevalent infectious diseases in Asia were COVID-19 and dengue fever, the prevalent infectious diseases in Africa were COVID-19, Ebola virus disease, plague, cholera, yellow fever, lassa fever and Rift valley fever, the prevalent infectious diseases in America were COVID-19 and dengue fever, the prevalent infectious disease in Europe was COVID-19.
$v.abstractInfoEn
$v.abstractInfoEn
$v.abstractInfoEn
Display Method: |
$v.abstractInfoEn
$v.abstractInfoEn
In April 2022, a total of 69 infectious diseases were reported globally, affecting 232 countries and regions. Except for influenza, the top five infectious diseases affecting greatest number of countries and regions were COVID-19 (232), dengue fever (29), measles (25), cholera (11) and leptospirosis (9). The top five infectious diseases with highest case fatality rates were Ebola virus disease (100.0%), Crimean-Congo hemorrhagic fever (40.0%), Middle East Respiratory Syndrome (34.4%), Lassa fever (19.3%) and monkeypox (5.3%). The top five infectious diseases with greatest number of deaths were COVID-19, malaria, dengue fever, cholera and measles. The prevalent infectious diseases in Asia were COVID-19 and dengue fever, the prevalent infectious diseases in Africa were COVID-19, Ebola virus disease, cholera, yellow fever, Lassa fever, malaria and measles, the prevalent infectious diseases in America were COVID-19, dengue fever, chikungunya fever and Zika virus disease, the prevalent infectious disease in Europe were COVID-19 and acute hepatitis of unknown aetiology.
$v.abstractInfoEn

CN 11-2928/R
ISSN 1003-9961
Established in:1986 , Monthly
Responsible Institution:National Health Commission of the People's Republic of China
Sponsor: Editorial Board of Disease Surveillance,National Institute for Communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention
-
Epidemiology of mumps in China, 2008-2010
-
Epidemiology of hand, foot and mouth disease in mainland of China, 2011
-
Epidemiology of hand foot and mouth disease in China, 2008
-
Population specific sentinel surveillance for HIV infection, syphilis and HCV infection in China, during 2010-2015
-
Infectious diarrhea epidemics caused by norovirus and its control strategy in China
-
Epidemiology of severe hand foot and mouth disease in the mainland of China, 2008-2011
-
Measles epidemiology in China,2014
-
Epidemiology of hand foot and mouth disease in mainland of China,2008-2009
-
Surveillance data of brucellosis in China,2005-2016
-
Analysis on surveillance data of brucellosis in China, 2009
-
捕获-再捕获方法在传染病报告信息完整性评价中的应用
-
数据处理中异常值的取舍
-
Application of seasonal trend model in influenza surveillance
-
Approaches to study disease clustering in space
-
近期布鲁氏菌病发病率上升的原因及防控措施建议
-
Epidemiology of hand foot and mouth disease in China, 2008
-
Multilocus sequence typing and its application
-
Progress in research on genome rearrangement of Yersinia pestis
-
Use of control chart in early warning of infectious disease
-
Establishment of LAMP-based rapid detection of Neisseria meningitides
-
全国各省法定报告疫情动态摘抄
-
Epidemiological survey of Helicobacter pylori infection in Tibetan population in Gangcha of Qinghai, 2017–2018
-
Reverse microbial etiology
-
Establishment of real-time PCR assays for rapid detection of Clostridium botulinum type A and B
-
Risk assessment of public health emergencies concerned in the mainland of China, September 2019
-
Progress in research of early diagnosis of blood-borne pathogens
-
Molecular characteristics and drug resistance of Aeromonas from environmental Sources in Ma'anshan, Anhui
-
Isolation of two rare Shewanella spp. from specimens of patients in Liaocheng in 2016
-
2019年3月中国甲乙丙类传染病疫情动态概要
-
Surveillance results of avian influenza virus in external environment in Quzhou, Zhejiang, 2013–2018
Search Type